share_log
Reuters ·  May 6 08:00
Rhythm Pharmaceuticals Inc - Remains on Track to Complete Submission of Snda to FDA Seeking a Label Expansion for Pediatric Patients in 1H 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment